| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | +2.73% | +0.67% | +2.06% | -0.66% | — |
| 14d | 4 | +100.00% | +6.09% | -1.04% | +7.13% | -3.09% | — |
| 30d | 4 | +75.00% | +1.48% | +0.26% | +1.22% | -4.92% | — |
| 60d | 4 | +100.00% | -2.63% | -0.64% | -1.99% | -0.38% | — |
| 90d | 4 | +75.00% | +8.94% | +1.77% | +7.17% | +13.03% | — |
| 180d | 4 | +75.00% | +16.13% | +5.23% | +10.90% | -1.04% | — |
| 1y | 4 | +100.00% | +46.53% | +11.89% | +34.64% | -9.72% | — |
| 2y | 4 | +100.00% | +21.49% | +26.09% | -4.60% | -36.86% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 57,000 | — | — | 57,000 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Jun 13, 2024 | Jun 17, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, CHIEF MEDICAL OFFICER | 15,000 | — | — | 0 | Jun 11, 2024 | Jun 13, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP, CHIEF MEDICAL OFFICER | 15,000 | $2.71 | $40.6K | 17,115 | Jun 11, 2024 | Jun 13, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, CHIEF MEDICAL OFFICER | 45,000 | $35.26 | $1.59M | 2,115 | Jun 7, 2024 | Jun 11, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, CHIEF MEDICAL OFFICER | 45,000 | — | — | 15,000 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, CHIEF MEDICAL OFFICER | 19,000 | $37.30 | $708.7K | 2,115 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP, CHIEF MEDICAL OFFICER | 19,000 | $10.38 | $197.2K | 21,115 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP, CHIEF MEDICAL OFFICER | 45,000 | $2.71 | $122.0K | 47,115 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, CHIEF MEDICAL OFFICER | 19,000 | — | — | 48,400 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,000 | — | — | 76,000 | Jun 16, 2022 | Jun 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, Chief Medical Officer | 4,600 | — | — | 67,400 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP, Chief Medical Officer | 4,600 | $10.38 | $47.7K | 6,715 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP, Chief Medical Officer | 4,600 | $42.94 | $197.5K | 2,115 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Jun 17, 2021 | Jun 21, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Jun 18, 2020 | Jun 19, 2020 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP, Chief Medical Officer | 2,115 | $4.73 | $10.0K | 2,115 | Jun 11, 2020 | Jun 12, 2020 ↗ | View → |